UBS lowered the firm’s price target on Corteva (CTVA) to $73 from $74 and keeps a Buy rating on the shares. The firm expects Q4 earnings for North America Chemicals and Packaging to be challenging, but with the sector on average down 10% over the last month, this negativity may already be priced in, the analyst tells investors in a research note.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CTVA: